Advertisement
UK markets close in 1 hour 15 minutes

  • FTSE 100

    8,129.63
    +50.77 (+0.63%)
     

  • FTSE 250

    19,823.94
    +221.96 (+1.13%)
     

  • AIM

    755.69
    +2.57 (+0.34%)
     

  • GBP/EUR

    1.1674
    +0.0018 (+0.15%)
     

  • GBP/USD

    1.2497
    -0.0014 (-0.11%)
     

  • Bitcoin GBP

    51,786.47
    +846.00 (+1.66%)
     

  • CMC Crypto 200

    1,340.22
    -56.32 (-4.04%)
     

  • S&P 500

    5,104.01
    +55.59 (+1.10%)
     

  • DOW

    38,278.59
    +192.79 (+0.51%)
     

  • CRUDE OIL

    83.96
    +0.39 (+0.47%)
     

  • GOLD FUTURES

    2,356.40
    +13.90 (+0.59%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,148.29
    +231.01 (+1.29%)
     

  • CAC 40

    8,091.08
    +74.43 (+0.93%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Here's Why Investors Should Retain Maximus (MMS) Stock Now

Zacks Equity Research
·2-min read

Maximus, Inc. MMS currently benefits from a solid track record of dividend payments.

MMS revenues are anticipated to grow 6.8% and 1.1% in 2022 and 2023, respectively.

Factors That Augur Well

Maximus has a solid track record of dividend payments. During fiscal 2021, 2020 and 2019, MAXIMUS paid out cash dividends of $68.8 million, $70.2 million and $63.9 million, respectively. Such moves indicate MAXIMUS’ commitment to creating value for its shareholders and underline its confidence in its business.

With more than 40 years of experience, MAXIMUS has over the years grown to be a leading operator of government health and human services programs globally. MMS’ business process management expertise, and its ability to deliver cost-effective, efficient and high-scale solutions position it well as a lucrative partner to governments.

Some Risks

MAXIMUS' current ratio at the end of the June quarter was pegged at 1.47, lower than the current ratio of 1.52, reported at the end of the prior-year quarter. Decreasing current ratio is not desirable as it indicates that the company may have problems meeting its short-term obligations.

Zacks Rank and Stocks to Consider

MAXIMUS' currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

ADVERTISEMENT

Some better-ranked stocks in the broader Zacks  Business Services  sector are Genpact Limited G, Automatic Data Processing, Inc. ADP and CRA International, Inc. CRAI.

Genpact carries a Zacks #2 Ranked at present. G has a long-term earnings growth expectation of 12.2%.

Genpact delivered a trailing four-quarter earnings surprise of 10.1%, on average.

ADP carries a Zacks Rank #2 (Buy) at present. ADP has a long-term earnings growth expectation of 12%.

ADP delivered a trailing four-quarter earnings surprise of 5%, on average.

CRA International carries a Zacks Rank of 2, currently. CRAI has a long-term earnings growth expectation of 14.3%.

CRAI delivered a trailing four-quarter earnings surprise of 26%, on average.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Automatic Data Processing, Inc. (ADP) : Free Stock Analysis Report
 
Charles River Associates (CRAI) : Free Stock Analysis Report
 
Genpact Limited (G) : Free Stock Analysis Report
 
Maximus, Inc. (MMS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research